NCT05158361

Brief Summary

The purpose of this study is to assess the effectiveness and safety of acupuncture for treating overactive bladder in adults.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
110

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 2, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 15, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

March 8, 2022

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 4, 2024

Status Verified

February 1, 2024

Enrollment Period

2.8 years

First QC Date

December 2, 2021

Last Update Submit

February 29, 2024

Conditions

Keywords

Overactive BladderAcupuncture

Outcome Measures

Primary Outcomes (1)

  • Change in number of micturition episodes per 24 hours

    Assessed by 72 h bladder diary

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

Secondary Outcomes (9)

  • Number of urinary urgency episodes per 24 hours

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

  • Number of daytime micturition episodes per 24 hours

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

  • Number of nocturia episodes per 24 hours

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

  • Change in mean volume voided per micturition

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

  • Change in OABSS questionnaire

    Before treatment (baseline), 8 week (post-treatment) and 12 week (follow-up)

  • +4 more secondary outcomes

Study Arms (2)

Acupuncture

EXPERIMENTAL

Participants will receive acupuncture.

Other: Acupuncture

Sham acupuncture

SHAM COMPARATOR

Participants will receive sham acupuncture.

Other: Sham acupuncture

Interventions

Participants will receive acupuncture, three times per week for eight weeks. The selected acupoints include bilateral BL33, BL35, SP6, and ST36. All acupoints areas have been sterilized before acupuncture. For BL33, a needle (Ф0.40×100mm) will be inserted with an angle of 60° in an inferomedial direction at a depth of 90-100mm. For BL35, the same needle will be inserted with a direction to the ischial rectal fossa at a depth of 60-70 mm deep. For SP6 and ST36, needles (Ф0.30×50mm) will be directly inserted at a depth of 25-30 mm deep. After the needles are inserted, a portable electro-acupuncture machine will be connected to the handles of needles located in BL33 and BL35 to provide the electrical stimulation for 30 minutes with a disperse-dense wave (4/20Hz). All current intensities will be as high as can be tolerated.

Acupuncture

The sham acupoints will be located at 20 mm outward to BL33, BL35, SP6, and ST36, and the needless will be inserted with a depth of 2 mm. The BL33 and BL35 will not receive any electrical stimulation, though the handles of needles will be connected to the same machine as the acupuncture group, and the parameter setting and course are also the same.

Sham acupuncture

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Present symptoms of urinary frequency and urgency for more than 3 months.
  • With a total score of more than 3 points on the overactive Bladder Symptom Score (OABSS) and a score of more than 2 points on question 3 of OABSS.

You may not qualify if:

  • With other lower urinary tract disorders (e.g. urinary tract infection, bladder outlet obstruction, neurogenic bladder, interstitial cystitis, etc.)
  • With previous pelvic floor surgery or a post-void residual urine volume more than 100 mL.
  • With neurological disease or psychiatric illness.
  • Taking medications affecting lower urinary tract function.
  • With contraindications to acupuncture.
  • Pregnant women.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Beijing, Beijing Municipality, 100053, China

RECRUITING

Related Publications (1)

  • Hargreaves E, Baker K, Barry G, Harding C, Zhang Y, Kandala NB, Zhang X, Kernohan A, Clarkson CE. Acupuncture for treating overactive bladder in adults. Cochrane Database Syst Rev. 2022 Sep 23;9(9):CD013519. doi: 10.1002/14651858.CD013519.pub2.

MeSH Terms

Conditions

Urinary Bladder, Overactive

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Ran Pang, MD

    Guang'anmen hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 2, 2021

First Posted

December 15, 2021

Study Start

March 8, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

March 4, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

The agreement for sharing IPD is not designed to be signed in informed consent form.

Locations